Anger is rising over India’s drug regulators for failing to issue a public advisory on counterfeit Abhayrab rabies vaccines. Despite alerts from Indian Immunologicals Limited, authorities chose a quiet probe, prompting ethical concerns after global warnings were issued by foreign regulators.
